InsidersTradesSigma
Discover the complete record of transactions filed by Buell Jennifer, Chief Executive Officer. Insider active across 2 companies, notably MiNK Therapeutics, Inc.. Cumulatively, 6 filings have been recorded. The latest transaction was disclosed on 2 January 2026 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
6 of 6 declarations
Jennifer Buell is the Chief Executive Officer and President at MiNK Therapeutics, Inc. and AGENUS INC. She leads the strategic operations of these companies, focusing on the development of immunological therapies. Her experience in the biopharmaceutical sector is a significant asset in achieving growth objectives.